These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1243984)

  • 1. Bioavailability of phenytoin. A comparison of two preparations.
    Stewart MJ; Ballinger BR; Devlin EJ; Miller AY; Ramsay AC
    Eur J Clin Pharmacol; 1975 Dec; 9(2-3):209-12. PubMed ID: 1243984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability and dissolution of proprietary and generic formulations of phenytoin.
    Soryal I; Richens A
    J Neurol Neurosurg Psychiatry; 1992 Aug; 55(8):688-91. PubMed ID: 1527539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the bioavailability of Polfa phenytoin tablets].
    Lazowski J; Lypka A; Zadrozyńska E; Pakszys W
    Neurol Neurochir Pol; 1978; 12(3):251-5. PubMed ID: 683430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma phenytoin levels produced by various phenytoin preparations.
    Sansom LN; O'Reilly WJ; Wiseman CW; Stern LM; Derham J
    Med J Aust; 1975 Oct; 2(15):593-5. PubMed ID: 1105111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of increased bioavailability of phenytoin tablets on serum phenytoin concentration in epileptic out-patients.
    Neuvonen PJ; Bardy A; Lehtovaara R
    Br J Clin Pharmacol; 1979 Jul; 8(1):37-41. PubMed ID: 552295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of serum phenytoin levels in epileptic patients who swallowed their phenytoin tablets with or without previous chewing.
    Bielmann P; Levac T
    Eur J Clin Pharmacol; 1978 Nov; 14(3):191-4. PubMed ID: 729613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison between microcrystalline and conventional phenytoin preparations: relative bioavailability and steady-state plasma concentrations.
    Boréus LO; Nergårdh A; Ehrnebo M; Theorell K
    J Neurol; 1980; 223(4):241-9. PubMed ID: 6157786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The bioavailability of phenytoin.
    Gugler R; Fröscher W; Eichelbaum M; Hildenbrand G
    J Neurol; 1977 Oct; 216(3):155-62. PubMed ID: 72133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability of three phenytoin preparations in healthy subjects and in epileptics.
    Rambeck B; Boenigk HE; Stenzel E
    Eur J Clin Pharmacol; 1977 Dec; 12(4):285-90. PubMed ID: 579344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bio-availability of phenytoin free-acid serum level determinations whilst using a lactose-based tablet-preparation (author's transl)].
    Fritsch G; Haidvogl M; Füger G; Urban C
    Monatsschr Kinderheilkd; 1980 Oct; 128(10):648-50. PubMed ID: 6107823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability of phenytoin from various pharmaceutical preparations in children.
    Manson JI; Beal SM; Magarey A; Pollard AC; O'Reilly WJ; Sansom LN
    Med J Aust; 1975 Oct; 2(15):590-2. PubMed ID: 1196223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability of phenytoin: comparison between three preparations.
    Kitzes R; Ackerman Z; Levy M; Frumerman I; Shved A; Garty M
    Isr J Med Sci; 1985 Apr; 21(4):323-6. PubMed ID: 3997494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability of phenytoin on single and multiple oral doses of two dosage forms in normal subjects.
    Kohda Y; Nishihara K; Isozaki S; Saitoh Y; Nakagawa F; Tamura Z
    J Pharmacobiodyn; 1983 Jan; 6(1):46-55. PubMed ID: 6854522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability of four brands of phenytoin tablets.
    Pentikäinen PJ; Neuvonen PJ; Elfving SM
    Eur J Clin Pharmacol; 1975 Dec; 9(2-3):213-8. PubMed ID: 1243985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of bioavailabilities of different phenytoin preparations.
    Fukuyama Y; Kitahara H; Goto T
    Brain Dev; 1982; 4(1):35-43. PubMed ID: 7065375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effectiveness of two oral phenytoin products and chronopharmacokinetics of phenytoin.
    Petker MA; Morton DJ
    J Clin Pharm Ther; 1993 Jun; 18(3):213-7. PubMed ID: 8345007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of formulation on dissolution and bioavailability of phenytoin tablets.
    Chakrabarti S; Belpaire F; Moerman E
    Pharmazie; 1980; 35(10):627-9. PubMed ID: 7454745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dissolution rates and bioavailability of phenytoin preparations (author's transl)].
    Brandau R; Wehnert HU
    Arzneimittelforschung; 1979; 29(3):552-5. PubMed ID: 582744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison on bioequivalence of four phenytoin preparations in patients with multiple-dose treatment.
    Tsai JJ; Lai ML; Yang YH; Huang JD
    J Clin Pharmacol; 1992 Mar; 32(3):272-6. PubMed ID: 1564132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study of phenytoin availability from pharmaceutical preparations].
    Leucuţa SE; Almaşu I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1986; 31(4):273-82. PubMed ID: 2951832
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.